Mirena IUD Lawsuits Progress in New Jersey Litigation, as Court Outlines Parameters for Contact with Treating Physicians, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous women in this proceeding who allegedly suffered uterine perforations and other Mirena complications due to spontaneous migration of the IUD.

Free Case Review
Our Firm is representing numerous plaintiffs in this litigation, and we continue to hear from other alleged victims of spontaneous IUD migration and related Mirena complications. We are pleased to see these cases moving forward.

Mirena IUD lawsuits (http://www.injurybeacon.com/mirena-iud/lawsuit/) continue to move forward in a consolidated litigation now underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to a Case Management Order issued on August 5th, the Court has established parameters governing the parties’ contact with Plaintiffs’ treating physicians. Among other things, the Order stipulates that Plaintiffs’ counsel may engage in ex parte communication with treating physicians in matters pertaining to a particular individual’s medical condition, including physician’s records, course of treatment, or product warnings. However, they may not discuss product liability issues or theories, or Defendants’ research documents or related materials. Physicians must also be informed that all such discussions are voluntary and can be declined. Finally, the Order prohibits Defense counsel from engaging in ex parte discussions with treating physicians, except as to deposition scheduling. (In Re: Mirena Litigation; Case No. 297)

“Our Firm is representing numerous plaintiffs in this litigation, and we continue to hear from other alleged victims of spontaneous IUD migration and related Mirena complications. We are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena IUD lawsuit evaluations to women who were seriously harmed, allegedly due to spontaneous migration of the IUD.

Mirena Lawsuits
The Mirena IUD is a long-acting method of birth control that was first approved by the U.S. Food & Drug Administration (FDA) in 2000. In 2009, its approved uses were expanded to include the treatment of heavy menstrual bleeding in women who wish to use an IUD for birth control. That same year, the FDA issued a warning letter to Bayer Healthcare Pharmaceuticals after finding that one of its Mirena promotions exaggerated the IUD’s benefits and understated its potentially serious side effects.

Court records indicate that more than 900 claims are pending in Bergen County Superior Court, all of which accuse Bayer Healthcare Pharmaceuticals of failing to warn users of the IUD that the device could spontaneously migrate from its proper position in the uterus long after its proper insertion by a healthcare provider. Plaintiffs further allege that this occurrence caused a number of painful and serious Mirena complications, including uterine perforations, organ damage, scarring and infertility. According to the complaints, many of the plaintiffs were forced to undergo surgery to locate and remove Mirena and repair damage caused by the IUD.

In addition to the cases pending in New Jersey, court documents show that at least 612 additional Mirena lawsuits involving similar allegations have been filed in a federal multicounty litigation now underway in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

Alleged victims of Mirena complications related to spontaneous IUD migration may be entitled to compensation from Bayer. To learn more about the ongoing Mirena litigation please visit Bernstein Liebhard LLP’s website, or the Firm's Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free and confidential Mirena case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website